StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) to a sell rating in a research note released on Saturday. Separately, Jefferies Financial Group initiated coverage on Lexicon Pharmaceuticals in a report on Tuesday, March 7th. They set a hold rating and a $3.00 target price on the stock. Lexicon Pharmaceuticals Trading Down 0.4 […]